Osseous Infections Caused by Aspergillus Species

Abstract

Background: Osteomyelitis caused by Aspergillus spp. is a severe, but rare, clinical entity. However, clear guidelines regarding the most effective medical management have not yet been established. The present study is a literature review of all such cases, in an effort to elucidate epidemiology, as well as the therapeutic management and the infection’s outcome. Methods: A thorough review of all reports of osteomyelitis of the appendicular and the axial skeleton, without the skull and the spine, caused by Aspergillus spp. was undertaken. Data about demographics, imaging techniques facilitating diagnosis, causative Aspergillus, method of mold isolation, antifungal treatment (AFT), surgical treatment, as well as the infection’s outcome were recorded and evaluated. Results: A total of 63 cases of osseous infection due to Aspergillus spp. were identified. The studied population’s mean age was 37.9 years. The most commonly affected site was the rib cage (36.8%). Most hosts suffered immunosuppressive conditions (76.2%). Regarding imaging methods indicating diagnosis, computer tomography (CT) was performed in most cases (42.9%), followed by plain X-ray (41.3%) and magnetic resonance imaging (MRI) (34.9%). The most frequent isolated mold was Aspergillus fumigatus (49.2%). Cultures and/or histopathology were used for definite diagnosis in all cases, while galactomannan antigen test was additionally used in seven cases (11.1%), polymerase chain reaction (PCR) in four cases (6.3%), and beta-d-glucan testing in three cases (4.8%). Regarding AFT, the preferred antifungal was voriconazole (61.9%). Most patients underwent surgical debridement (63.5%). The outcome was successful in 77.5%. Discussion: Osteomyelitis due to Aspergillus spp. represents a severe infection. The available data suggest that prolonged AFT in combination with surgical debridement is the preferred management of this infection, while identification of the responsible mold is of paramount importance.

Neglected extensive Aspergillus osteomyelitis of the pelvis, femur, and vertebra in an immunocompetent patient: A case report

“…Spread from an adjacent pulmonary infection is observed mainly in children, whereas hematogenous spread is the usual route of long bone involvement in adults. 7 , 11 – 13 …”

Fungal Prosthetic Joint Infection in Revised Knee Arthroplasty: An Orthopaedic Surgeon’s Nightmare

“…Voriconazole was firstly introduced in 2003 and has been proven the drug of choice against Aspergillus spp. [ 43 , 44 ]. This compound has spectacularly transformed the management of Aspergillus infections in the last decades.…”

“…This compound has spectacularly transformed the management of Aspergillus infections in the last decades. This agent has all the features of azole agents, while being far less hepatotoxic and much less nephrotoxic than amphotericin compounds [ 44 , 45 ].…”

Fungal arthritis: A challenging clinical entity

“…Serum assays for BDG are not specific to Aspergillus . Galactomannan antigen test has prognostic value with a serial decline in the serum levels indicating an effective antifungal treatment[ 27 ].…”